The global short bowel syndrome market is expected to grow at a CAGR of around 6.7% during 2021-2027. This report on global short bowel syndrome market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global short bowel syndrome market by segmenting the market based on drug class, application and region. Also, detailed profiles of companies operating in the short bowel syndrome market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
- Increasing Acceptance of Short Bowel Syndrome Treatment
- Growing Prescriptions for the Gattex Therapy
- Strong Pipeline Drugs
Market Challenges
- Dangerous Side Effects Restrict Demand
- Changes in Splanchnic Perfusion
Historical & Forecast Period
Base Year: 2020
Historical Period: 2016-2019
Forecast Period: 2021-2027
Market by Drug Class
- Glucagon-like Peptide-2 (GLP-2)
- Growth Hormone
- Glutamine
- Others
Market by Application
- Hospitals
- Clinics
Market by Region
- Europe
o Germany
o United Kingdom
o France
o Italy
o Spain
o Russia
o Netherlands
o Rest of Europe - North America
o United States
o Canada - Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Rest of Asia Pacific - Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America - Middle East & Africa
o Saudi Arabia
o Turkey
o Iran
o United Arab Emirates
o Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Short Bowel Syndrome Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Short Bowel Syndrome Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Short Bowel Syndrome Market by Drug Class
5.1. Introduction
5.2. Glucagon-like Peptide-2 (GLP-2)
5.3. Growth Hormone
5.4. Glutamine
5.5. Others
6. Global Short Bowel Syndrome Market by Application
6.1 Introduction
6.2 Hospitals
6.3 Clinics
7. Global Short Bowel Syndrome Market by Region
7.1 Introduction
7.2 Europe
7.2.1 Germany
7.2.2 United Kingdom
7.2.3 France
7.2.4 Italy
7.2.5 Spain
7.2.6 Russia
7.2.7 Netherlands
7.2.8 Rest of the Europe
7.3 North America
7.3.1 United States
7.3.2 Canada
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 South Korea
7.4.5 Australia
7.4.6 Indonesia
7.4.7 Rest of the Asia Pacific
7.5 Latin America
7.5.1 Mexico
7.5.2 Brazil
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 Turkey
7.6.2 Iran
7.6.3 United Arab Emirates
7.6.4 Rest of Middle East & Africa
8. SWOT Analysis
9. Porter’s Five Forces
10. Market Value Chain Analysis
11. Competitive Landscape
11.1 Competitive Scenario
11.2 Company Profiles
11.2.1 Shire plc (Takeda Pharmaceutical Company Limited)
11.2.2 Zealand Pharma A/S
11.2.3 Sancilio & Company, Inc
11.2.3 OxThera
11.2.4 Nutrinia Ltd.
11.2.5 Ardelyx, Inc.
11.2.6 Emmaus Life Sciences, Inc.
11.2.7 GLyPharma Therapeutic, Inc. (Pfizer Inc.)
11.2.8 Merck
11.2.9 Naia Pharmaceuticals, Inc.
List of Figures
Figure 1: Global Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 2: Global Short Bowel Syndrome Market by Drug Class, 2020
Figure 3: Global Short Bowel Syndrome Market by Application, 2020
Figure 4: Global Short Bowel Syndrome Market by Region, 2020
Figure 5: Global Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 6: Global Short Bowel Syndrome Market by Drug Class (in %), 2020 & 2027
Figure 7: Global GLP-2 Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 8: Global GLP-2 Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 9: Global Growth Hormone Microscopes Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 10: Global Growth Hormone Microscopes Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 11: Global Glutamine Probe Microscopes Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 12: Global Glutamine Probe Microscopes Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 13: Global Other Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 14: Global Other Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 15: Global Short Bowel Syndrome Market by Application (in %), 2020 & 2027
Figure 16: Global Hospitals Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 17: Global Hospitals Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 18: Global Clinic Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 19: Global Clinic Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 20: Global Short Bowel Syndrome Market by Region (in %), 2020 & 2027
Figure 21: Europe Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 22: Europe Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 23: Europe Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 24: Germany Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 25: United Kingdom Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 26: France Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 27: Italy Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 28: Spain Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 29: Russia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 30: Netherlands Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 31: North America Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 32: North America Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 33: North America Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 34: United States Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 35: Canada Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 36: Asia Pacific Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 37: Asia Pacific Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 38: Asia Pacific Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 39: China Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 40: Japan Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 41: India Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 42: South Korea Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 43: Australia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 44: Indonesia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 45: Latin America Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 46: Latin America Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 47: Latin America Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 48: Mexico Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 49: Brazil Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 50: Argentina Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 51: Middle East & Africa Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 52: Middle East & Africa Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 53: Middle East & Africa Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 54: Saudi Arabia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 55: Turkey Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 56: Iran Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 57: UAE Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 58: Market Value Chain
List of Tables
Table 1: Global Short Bowel Syndrome Market Portraiture
Table 2: Global Short Bowel Syndrome Market by Drug Class (in US$ Million), 2020 & 2027
Table 3: Global Short Bowel Syndrome Market by Application (in US$ Million), 2020 & 2027
Table 4: Global Short Bowel Syndrome Market by Region (in US$ Million), 2020 & 2027
Table 5: Europe Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 6: North America Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 7: Asia Pacific Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 8: Latin America Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 9: Middle East & Africa Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 10: List of Key Players
- Description
-
The global short bowel syndrome market is expected to grow at a CAGR of around 6.7% during 2021-2027. This report on global short bowel syndrome market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global short bowel syndrome market by segmenting the market based on drug class, application and region. Also, detailed profiles of companies operating in the short bowel syndrome market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
- Increasing Acceptance of Short Bowel Syndrome Treatment
- Growing Prescriptions for the Gattex Therapy
- Strong Pipeline Drugs
Market Challenges
- Dangerous Side Effects Restrict Demand
- Changes in Splanchnic Perfusion
Historical & Forecast Period
Base Year: 2020
Historical Period: 2016-2019
Forecast Period: 2021-2027Market by Drug Class
- Glucagon-like Peptide-2 (GLP-2)
- Growth Hormone
- Glutamine
- Others
Market by Application
- Hospitals
- Clinics
Market by Region
- Europe
o Germany
o United Kingdom
o France
o Italy
o Spain
o Russia
o Netherlands
o Rest of Europe - North America
o United States
o Canada - Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Rest of Asia Pacific - Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America - Middle East & Africa
o Saudi Arabia
o Turkey
o Iran
o United Arab Emirates
o Rest of Middle East & Africa
- Table of Content
-
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Short Bowel Syndrome Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Short Bowel Syndrome Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Short Bowel Syndrome Market by Drug Class
5.1. Introduction
5.2. Glucagon-like Peptide-2 (GLP-2)
5.3. Growth Hormone
5.4. Glutamine
5.5. Others
6. Global Short Bowel Syndrome Market by Application
6.1 Introduction
6.2 Hospitals
6.3 Clinics
7. Global Short Bowel Syndrome Market by Region
7.1 Introduction
7.2 Europe
7.2.1 Germany
7.2.2 United Kingdom
7.2.3 France
7.2.4 Italy
7.2.5 Spain
7.2.6 Russia
7.2.7 Netherlands
7.2.8 Rest of the Europe
7.3 North America
7.3.1 United States
7.3.2 Canada
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 South Korea
7.4.5 Australia
7.4.6 Indonesia
7.4.7 Rest of the Asia Pacific
7.5 Latin America
7.5.1 Mexico
7.5.2 Brazil
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 Turkey
7.6.2 Iran
7.6.3 United Arab Emirates
7.6.4 Rest of Middle East & Africa
8. SWOT Analysis
9. Porter’s Five Forces
10. Market Value Chain Analysis
11. Competitive Landscape
11.1 Competitive Scenario
11.2 Company Profiles
11.2.1 Shire plc (Takeda Pharmaceutical Company Limited)
11.2.2 Zealand Pharma A/S
11.2.3 Sancilio & Company, Inc
11.2.3 OxThera
11.2.4 Nutrinia Ltd.
11.2.5 Ardelyx, Inc.
11.2.6 Emmaus Life Sciences, Inc.
11.2.7 GLyPharma Therapeutic, Inc. (Pfizer Inc.)
11.2.8 Merck
11.2.9 Naia Pharmaceuticals, Inc. - List of Figures & Tables
-
List of Figures
Figure 1: Global Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 2: Global Short Bowel Syndrome Market by Drug Class, 2020
Figure 3: Global Short Bowel Syndrome Market by Application, 2020
Figure 4: Global Short Bowel Syndrome Market by Region, 2020
Figure 5: Global Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 6: Global Short Bowel Syndrome Market by Drug Class (in %), 2020 & 2027
Figure 7: Global GLP-2 Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 8: Global GLP-2 Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 9: Global Growth Hormone Microscopes Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 10: Global Growth Hormone Microscopes Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 11: Global Glutamine Probe Microscopes Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 12: Global Glutamine Probe Microscopes Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 13: Global Other Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 14: Global Other Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 15: Global Short Bowel Syndrome Market by Application (in %), 2020 & 2027
Figure 16: Global Hospitals Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 17: Global Hospitals Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 18: Global Clinic Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 19: Global Clinic Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 20: Global Short Bowel Syndrome Market by Region (in %), 2020 & 2027
Figure 21: Europe Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 22: Europe Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 23: Europe Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 24: Germany Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 25: United Kingdom Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 26: France Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 27: Italy Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 28: Spain Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 29: Russia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 30: Netherlands Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 31: North America Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 32: North America Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 33: North America Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 34: United States Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 35: Canada Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 36: Asia Pacific Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 37: Asia Pacific Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 38: Asia Pacific Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 39: China Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 40: Japan Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 41: India Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 42: South Korea Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 43: Australia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 44: Indonesia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 45: Latin America Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 46: Latin America Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 47: Latin America Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 48: Mexico Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 49: Brazil Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 50: Argentina Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 51: Middle East & Africa Short Bowel Syndrome Market (in US$ Million), 2016-2020
Figure 52: Middle East & Africa Short Bowel Syndrome Market (in US$ Million), 2021-2027
Figure 53: Middle East & Africa Short Bowel Syndrome Market by Country (in %), 2020 & 2027
Figure 54: Saudi Arabia Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 55: Turkey Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 56: Iran Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 57: UAE Short Bowel Syndrome Market (in US$ Million), 2016-2027
Figure 58: Market Value ChainList of Tables
Table 1: Global Short Bowel Syndrome Market Portraiture
Table 2: Global Short Bowel Syndrome Market by Drug Class (in US$ Million), 2020 & 2027
Table 3: Global Short Bowel Syndrome Market by Application (in US$ Million), 2020 & 2027
Table 4: Global Short Bowel Syndrome Market by Region (in US$ Million), 2020 & 2027
Table 5: Europe Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 6: North America Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 7: Asia Pacific Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 8: Latin America Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 9: Middle East & Africa Short Bowel Syndrome Market by Country (in US$ Million), 2020 & 2027
Table 10: List of Key Players